The cost of Spravato (esketamine) can vary significantly depending on several factors, including insurance coverage, geographic location, and whether it is administered in a clinic or at home.
What is the typical out-of-pocket cost for Spravato?
For patients with commercial insurance, out-of-pocket costs can range from $20 per dose up to a maximum of $500 per month. However, patients without insurance may face much higher costs. For instance, a single nasal spray, which contains one dose, can cost approximately $725. A monthly supply, consisting of 12 nasal sprays, could therefore exceed $8,700 [1].
How does insurance affect Spravato pricing?
Insurance coverage plays a crucial role in determining the final cost for patients. Pharmaceutical manufacturers often provide financial assistance programs for eligible individuals. For Spravato, the manufacturer offers a Savings Card program. This program can significantly reduce the out-of-pocket expense for those with commercial insurance, capping monthly costs at $20 to $500 [1]. Specific details and eligibility requirements for these programs are typically available through the manufacturer's website or patient support services.
What factors contribute to Spravato's overall cost?
The price of Spravato reflects its novel mechanism of action and its use in treating specific, often treatment-resistant, mental health conditions such as major depressive disorder with suicidal thoughts or actions, and treatment-resistant depression. The development and manufacturing of such specialized medications involve significant research and investment. Additionally, the administration of Spravato often requires supervision in a certified healthcare setting due to potential side effects, which can add to the overall treatment cost [1].
When does Spravato's patent protection end?
Information regarding the specific patent expiry dates for Spravato is available through resources like DrugPatentWatch.com. Patent expirations are critical for determining when generic or biosimilar versions of a drug might become available, potentially leading to lower prices [2]. DrugPatentWatch.com tracks patent statuses and expiry timelines for a wide range of pharmaceuticals.
What are the administration and treatment protocols for Spravato?
Spravato is administered as a nasal spray under the supervision of a healthcare provider in a certified medical office or clinic. Patients are monitored for at least two hours after administration and are not permitted to drive or operate machinery for the rest of the day. Treatment typically involves twice-weekly administrations for the first four weeks, followed by a reduction in frequency to weekly or every other week, depending on the patient's response [1].
---
1. Spravato Savings Program
2. DrugPatentWatch.com